Vandetanib for thyroid cancer

被引：0
|
作者：
Takahashi, Shunji [1 ]
机构：
[1] JFCR, Canc Inst Hosp, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISY-6-1
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Vandetanib for thyroid cancer
    Iley Ozerlat
    Nature Reviews Endocrinology, 2012, 8 (11) : 627 - 627
  • [2] Vandetanib for the Treatment of Thyroid Cancer
    Langmuir, P. B.
    Yver, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (01) : 71 - 80
  • [3] Vandetanib In Medullary Thyroid Cancer
    Frampton, James E.
    DRUGS, 2012, 72 (10) : 1423 - 1436
  • [4] Use of vandetanib in medullary thyroid cancer
    Marquez Fernandez, E.
    Marmesat Rodas, B.
    Quesada Sanz, M. P.
    Guerra Estevez, D.
    Villanueva Jimenez, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 587 - 587
  • [5] Vandetanib for the treatment of thyroid cancer: an update
    Karras, Spyridon
    Anagnostis, Panagiotis
    Krassas, Gerasimos E.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (03) : 469 - 481
  • [6] VANDETANIB THERAPY IN MEDULLARY THYROID CANCER
    Grabowski, P.
    Briest, F.
    Baum, R. P.
    Zaknun, J. J.
    Kulkarni, H. R.
    Zeitz, M.
    Hoersch, D.
    DRUGS OF TODAY, 2012, 48 (11) : 723 - 733
  • [7] The safety of vandetanib for the treatment of thyroid cancer
    Tsang, Venessa H. M.
    Robinson, Bruce G.
    Learoyd, Diana L.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (08) : 1107 - 1113
  • [8] Vandetanib (Caprelsa) for Medullary Thyroid Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1381): : 3 - 4
  • [9] Vandetanib for the Treatment of Medullary Thyroid Cancer
    Chau, Nicole G.
    Haddad, Robert I.
    CLINICAL CANCER RESEARCH, 2013, 19 (03) : 524 - 529
  • [10] Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
    Degrauwe, Nils
    Sosa, Julie Ann
    Roman, Sanziana
    Deshpande, Hari A.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
12345